Newer investor very confused I invested 3 weeks or so ago into AST after reading everything. Obviously it dropped 25% right after my first investment. I held and it went back up. So far so good. How is this stock …
The bull case for **Autodesk (ADSK)** rests on its massive economic moat, highly recurring subscription revenue, and transition into an "AI-native" platform. Trading at a discount to historical multiples despite strong cash generation, ADSK presents a compelling opportunity for investors …
TL;DR: Collegium ($COLL) sells patent-protected extended-release drugs for pain and ADHD. Asset-light, 61% gross margins, \~$290M owner earnings, revenue compounding \~20% for five years. Including \~$488M of net debt, the whole enterprise trades around 5.6x owner earnings. I think the …
A couple of weeks ago I posted a turnaround thesis on Under Armour. It got a lot more attention than I expected, and while plenty of people disagreed with me, I appreciated the pushback because it made me think harder …
Back in 2000-2005 when biotech stocks ruled for a cycle and every single one you bought was basically a winner, I think the same thing has been forming for the past few months in a world post-AI bump. Biotech seems …
Rule tested: each year buy the Mag7 stock with the lowest positive year-end trailing P/E from the prior year, hold for 1 year, rebalance annually. Selections were mostly Apple 2013–2020, then Meta 2021–2024, then Google 2025. Apple’s PE was very …
For context behind the numbers: Cognizant’s latest finance feed had it around **$41.07**, with a P/E near **8.9x**. Its Q1 report showed **$5.4B revenue**, **5.8% YoY growth**, and **21% quarterly bookings growth**, while Reuters also noted the company guided Q2 …
Just a few months ago, Microsoft, Amazon, and Google were essentially set it and forget it stocks. No one questioned them. You bought the shares, reinvested the dividends, and moved on. Now something has changed quietly. These companies still dominate …
NVDA has been flat for a year now, ratios keeps compressing but the stock is going nowhere it seems. I thought after the recent breakout in april, we would consolidate higher, but no, it came back down to where it …
Wondering what you think of today’s move in software (IGV). Was this simply institutions closing their shorts within software names, or do we think they are rebalancing into these names? We’ve seen bounces like this over the last couple months, …